GANYMED PHARMACEUTICALS AG
USPTO Trademark & Patent Filings
Trademark applications and grants for Ganymed Pharmaceuticals Ag. Ganymed Pharmaceuticals Ag has 1 trademark applications. The latest application filed is for "MICROGATE"
- Company Aliases
- Tureci, Ozlem
- ozlem tureci
- TURECI; Ozlem - Mainz DE
- Tureci; Ozlem - Mainz DE
| State Incorporated | GERMANY |
| Entity Type | CORPORATION |
| Address | PHILLIP-VON-ZABERN-PLATZ 1 MAINZ GERMANY 55116 |
Trademarks Patents
| Patent Application | Date |
|---|---|
| CLAUDIN-6-SPECIFIC IMMUNORECEPTORS AND T CELL EPITOPES 20220306711 - 17/712562 SAHIN; Ugur ; et al. | 2022-09-29 |
| ANTIGEN-SPECIFIC T CELL RECEPTORS AND T CELL EPITOPES 20220288180 - 17/680021 Sahin; Ugur ; et al. | 2022-09-15 |
| RNA CONSTRUCTS AND USES THEREOF 20220273820 - 17/565921 Sahin; Ugur ; et al. | 2022-09-01 |
| RECOMBINANT VACCINES AND USE THEREOF 20220257783 - 17/688707 Tureci; Ozlem ; et al. | 2022-08-18 |
| RNA CONSTRUCTS AND USES THEREOF 20220249704 - 17/565842 Sahin; Ugur ; et al. | 2022-08-11 |
| Therapy involving antibodies against Claudin 18.2 for treatment of cancer 11,395,852 - 16/158,187 Sahin , et al. July 26, 2 | 2022-07-26 |
| Claudin-6-specific immunoreceptors and t cell epitopes 11,345,731 - 16/444,510 Sahin , et al. May 31, 2 | 2022-05-31 |
| Antigen-specific T cell receptors and T cell epitopes 11,311,611 - 16/121,414 Sahin , et al. April 26, 2 | 2022-04-26 |
| Recombinant vaccines and use thereof 11,298,426 - 15/895,402 Tureci , et al. April 12, 2 | 2022-04-12 |
| Antibodies useful in cancer diagnosis 11,279,757 - 16/641,160 Mitnacht-Kraus , et al. March 22, 2 | 2022-03-22 |
Mark Image Registration | Serial | Trademark Application Date |
|---|---|
"MICROGATE" 2708625 76307698 |
MICROGATE 2001-08-31 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 